PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsFor46
For46
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
104 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Colorectal neoplasmsD015179———2184—33
Pancreatic neoplasmsD010190EFO_0003860C2511221218
Liver neoplasmsD008113EFO_1001513C22.0—4—149
Neoplasm metastasisD009362EFO_0009708——32218
NeoplasmsD009369—C80———123
EmphysemaD004646EFO_0000464J43———1—1
Pulmonary emphysemaD011656—J43———1—1
AmyloidosisD000686EFO_1001875E85———1—1
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
CarcinomaD002277—C80.0—81—413
MelanomaD008545——231——6
Rectal neoplasmsD012004———41—16
NeutropeniaD009503—D70—11——2
Macular edemaD008269———12——2
EdemaD004487HP_0000969R60.9—12——2
Chemotherapy-induced febrile neutropeniaD064146————1——1
Neurotoxicity syndromesD020258—G92——1——1
SchizophreniaD012559EFO_0000692F20——1——1
Head and neck neoplasmsD006258————1——1
Show 2 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
AdenocarcinomaD000230——17——19
Hepatocellular carcinomaD006528—C22.0—4——48
Pancreatic ductal carcinomaD021441——22———4
Stomach neoplasmsD013274EFO_0003897C16—2———2
Esophageal neoplasmsD004938—C15—2———2
ObesityD009765EFO_0001073E66.9—1——12
LymphomaD008223—C85.911———2
LeukemiaD007938—C95—2———2
Prostatic neoplasmsD011471—C6121———2
Gastrointestinal neoplasmsD005770—C26.9—1——12
Show 20 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Non-hodgkin lymphomaD008228—C85.91————1
Follicular lymphomaD008224—C821————1
Multiple myelomaD009101—C90.01————1
Plasma cell neoplasmsD054219——1————1
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
DiarrheaD003967HP_0002014R19.7————22
Vascular system injuriesD057772—T14.8————11
Overactive urinary bladderD053201EFO_1000781N32.81————11
Nutrition disordersD009748EFO_0001069—————11
Psychosocial functioningD000083623——————11
ExerciseD015444EFO_0000483—————11
AnorexiaD000855HP_0002039R63.0————11
Anorexia nervosaD000856EFO_0004215F50.0————11
Nasopharyngeal carcinomaD000077274——————11
RadiotherapyD011878——————11
Show 11 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common name—
INN—
Description
—
Classification
Unknown
Drug class—
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)—
Identifiers
PDB—
CAS-ID—
RxCUI—
ChEMBL ID—
ChEBI ID—
PubChem CID—
DrugBank—
UNII ID—
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
0 adverse events reported
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use